Cargando…
Targeting Mononuclear Phagocyte Receptors in Cancer Immunotherapy: New Perspectives of the Triggering Receptor Expressed on Myeloid Cells (TREM-1)
Inflammatory cells are major players in the onset of cancer. The degree of inflammation and type of inflammatory cells in the tumor microenvironment (TME) are responsible for tilting the balance between tumor progression and regression. Cancer-related inflammation has also been shown to influence th...
Autores principales: | Raggi, Federica, Bosco, Maria Carla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281211/ https://www.ncbi.nlm.nih.gov/pubmed/32456204 http://dx.doi.org/10.3390/cancers12051337 |
Ejemplares similares
-
TREM-2 (triggering receptor expressed on myeloid cells 2) is a phagocytic receptor for bacteria
por: N'Diaye, Elsa-Noah, et al.
Publicado: (2009) -
The triggering receptor expressed on myeloid cells (TREM) in inflammatory bowel disease pathogenesis
por: Genua, Marco, et al.
Publicado: (2014) -
Triggering receptor expressed on myeloid cells-1 (TREM-1): a new player in antiviral immunity?
por: Roe, Kelsey, et al.
Publicado: (2014) -
Triggering receptor expressed on myeloid cells 2 (TREM2) regulates phagocytosis in glioblastoma
por: Peshoff, Mekenzie M., et al.
Publicado: (2023) -
Triggering Receptor Expressed on Myeloid Cells (TREM)-2 Impairs Host Defense in Experimental Melioidosis
por: Weehuizen, Tassili A. F., et al.
Publicado: (2016)